Capital Counsel’s Bristol-Myers Squibb BMY Stock Holding History

Capital Counsel’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-8,264	Closed	-$568K	–	72
2015 Q4	$568K	Hold	8,264	–	–	0.03%	70
2015 Q3	$489K	Sell	8,264 -640	-7%	-$40.6K	0.03%	72
2015 Q2	$592K	Buy	8,904 +500	+6%	+$33K	0.03%	74
2015 Q1	$542K	Hold	8,404	–	–	0.03%	80
2014 Q4	$496K	Buy	8,404 +2,000	+31%	+$113K	0.02%	83
2014 Q3	$328K	Hold	6,404	–	–	0.02%	101
2014 Q2	$311K	Sell	6,404 -11	-0.2%	-$542	0.02%	110
2014 Q1	$333K	Hold	6,415	–	–	0.02%	106
2013 Q4	$341K	Buy	6,415 +575	+10%	+$29.3K	0.02%	110
2013 Q3	$270K	Buy	5,840 +700	+14%	+$30.7K	0.02%	108
2013 Q2	$230K	Buy	+5,140	New	+$223K	0.01%	111

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital Counsel's BMY Position: Q1 2016 in Review

Capital Counsel sold out of Bristol-Myers Squibb (BMY) in Q1 2016, closing a stake of 8,264 shares — an estimated $568K sold.

Capital Counsel first reported a position in BMY in Q2 2013 and held it in 11 quarters. The position peaked at $592K in Q2 2015. 1,523 funds tracked by Wall St. Rank hold BMY as of Q1 2016.

Capital Counsel reported no remaining Bristol-Myers Squibb position as of Q1 2016 after selling out during the quarter.
Capital Counsel sold 8,264 Bristol-Myers Squibb shares in Q1 2016, an estimated $568K.
Capital Counsel first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 11 quarters.
Capital Counsel's Bristol-Myers Squibb position peaked at $592K in Q2 2015.
1,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2016.

Based on Capital Counsel's 13F filing for Q1 2016, filed 13 May 2016.